CURANEX PHARMACEUTICALS INC (CURX:NASDAQ)

$0.343 0.0145 (4.414%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) News Sources

Curanex Provides Operational Update on Key Regulatory Milestones

25-02-2026

yahoo.com

Curanex Forms World Class Scientific Advisory Board

05-03-2026

yahoo.com

Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board

11-03-2026

yahoo.com

Curanex Expands Scientific Advisory Board With Two Distinguished Researchers

12-03-2026

yahoo.com

Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission

18-03-2026

yahoo.com

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission

30-03-2026

yahoo.com

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

02-04-2026

yahoo.com

Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care

06-04-2026

yahoo.com

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

08-04-2026

yahoo.com

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

14-05-2026

yahoo.com

CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) Sentiment Trend

0 25 50 75 100 67 78 70 68 76 83 90 84 85 89 25-02-2026 05-03-2026 11-03-2026 12-03-2026 18-03-2026 30-03-2026 02-04-2026 06-04-2026 08-04-2026 14-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) FAQs

toggle

What is the current price of CURANEX PHARMACEUTICALS INC (CURX:NASDAQ)?

The current price of CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) is $0.343.


toggle

CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) absolute price change since previous trading day?

The absolute price change of CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) since the previous trading day is $0.0145.


toggle

CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) percentage price change since previous trading day?

The percentage price change of CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) since the previous trading day is 4.414%.


toggle

What is the most recent average sentiment score for CURANEX PHARMACEUTICALS INC (CURX:NASDAQ)?

The most recent average sentiment score for CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) is 79 out of 100.


toggle

What is the most recent average sentiment for CURANEX PHARMACEUTICALS INC (CURX:NASDAQ)?

The most recent sentiment for CURANEX PHARMACEUTICALS INC (CURX:NASDAQ) is .


SEC-8K** Filing Available For CURANEX PHARMACEUTICALS INC (CURX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.